Robert Oliva - Feb 23, 2022 Form 4 Insider Report for Novo Integrated Sciences, Inc. (NVOS)

Role
Director
Signature
/s/ Christopher David, as Attorney-in-fact for Robert Oliva
Stock symbol
NVOS
Transactions as of
Feb 23, 2022
Transactions value $
$0
Form type
4
Date filed
2/24/2022, 03:05 PM
Next filing
Apr 21, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding NVOS Common Stock 208K Feb 23, 2022 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction NVOS Stock Option (right to buy) Award $0 +94K $0.00 94K Feb 23, 2022 Common Stock 94K $1.33 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents a grant approved by the issuer's Board of Directors. The stock option vests, and becomes exercisable, with respect to 7,833 shares each month, beginning on the date of grant, until December 23, 2022 and with respect to 7,832 shares on January 23, 2023.